prescription reporting with immediate medication ...llrs.org/llrs 2016 pdfs/prescription reporting...

25
Prescription Reporting with Immediate Medication Utilization Mapping (PRIMUM) Joseph R. Hsu, MD Professor, Orthopaedic Trauma Director, Limb Lengthening and Deformity Service

Upload: others

Post on 11-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

Prescription Reporting with Immediate Medication Utilization Mapping (PRIMUM)

Joseph R. Hsu, MDProfessor, Orthopaedic Trauma

Director, Limb Lengthening and Deformity Service

Page 2: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 2

Page 3: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 3

More people die in USA per year of poisoning than MVC.

90%ofallpoisoningsarenaracotics related

Page 4: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 4

Is this a problem for US? NC?

Prescribingratesper100citizens,2012U.S.healthcareproviderswrote259millionprescriptionsforopioidpainkillersin2012.

PrescriptionratesarehighestintheSoutheast(Photo:SOURCECDC(MorbidityandMortalityWeeklyReport);Credit:JulieSnider,USATODAY)

Page 5: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 5

OpportunityforSystem-WideIntervention

Page 6: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 6

Prescription Reporting with Immediate Medication Utilization Mapping (PRIMUM)

Principal Investigators: Rachel Seymour, PhD, and Joseph Hsu, MD Co-investigators: Michael Beuhler, MD; Michael Bosse, MD; Stephen Colucciello, MD; Michael Gibbs, MD; Steven Jarrett, PharmD; Michael Runyon, MD; Animita Saha, MD; Brad Watling, MD; Christopher Griggs, MD; Stephen Wyatt, DO; Daniel Leas, MD; Sharon Schiro, PhD; Meghan Wally, MSPH

• Goals: 1) To identify patients at risk for misuse, abuse, and diversion of prescription opioids

and benzodiazepines. 2) To provide critical information to the prescriber at the point of care in order to inform

clinical decision-making

Page 7: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 7

Carolinas HealthCare System

• 40+ hospitals• 900+ care locations• 15,000+ clinicians• 10m+ annual encounters

Page 8: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 8

PRIMUM: Rule logic and alert system

• Prescriber selects controlled substance

• EMR searches patient chart for defined risk factors for abuse/misuse/diversion

• If risk factors identified, provides prescriber with alert

• Prescriber can continue or discontinue script.

Page 9: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 9

Identifying and Selecting the Triggers• Literature Review

– Risk factors for misuse, abuse, diversion, or overdose – Included demographic characteristics, medical conditions, prescription history, and high

risk behaviors• Expert Panel• Select triggers that are:

– Consistently and accurately documented in EMR– Searchable in the EMR– Objective!

Page 10: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 10

Intervention Phases• April-May 2015: 30-day baseline data gathered silently• May 26, 2015: Pilot test sites went live with alert

– CMC Orthopaedics – MMP and MP– CMC-Main ED– CMC-Lincoln and CMC-Pineville EDs– Internal Medicine clinic at MP– Elizabeth Family Medicine– CHC Urgent Care Morrocroft

• July 21, 2015: Alert went live across all Cerner-driven CHS facilities (outpatient)

• October 27, 2015: Alert live in ALL Cerner facilities (inpatient and outpatient)

Page 11: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 11

Initial Triggers• Early refill/Current prescription with >30% remaining expected • 3+ visits to ED or Urgent Care with onsite treatment with opioids (not

including visits leading to admission) within previous 30 days • 3+ prescriptions for opioids or benzodiazepines within previous 30 days • Previous presentation for overdose within the EMR• Positive screen for blood alcohol, cocaine, or marijuana within the EMR

Page 12: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 12

“Silent” Surveillance Phase 1: Tuning the Logic

• Made decision to run the rule when prescriber clicks to prescribe narcotic

• Programmed initial triggers into the rule• Ran the rule silently (no alert shown to prescribers) to test and

collect baseline data• Modified triggers to appropriate rates

Page 13: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 13

Final PRIMUM Logic

• Early refill/Current prescription with >50% remaining expected• 2+ visits to ED or Urgent Care with onsite treatment with opioids

(not including visits leading to admission) within previous 30 days • 3+ prescriptions for opioids or benzodiazepines within previous 30

days • Previous presentation for overdose within the EMR• Positive screen for blood alcohol, cocaine, or marijuana within the

EMR

Page 14: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 14

Baseline DataOverallEncounters*

N=770,431

OverallEncounterswithNarcotic/Benzo Prescription

N=45,9615.97%ofOverall

PrescribingEncountersw/AlertN=9,998

21.8%ofPrescribingEncounters

1.30%ofTotal *Excludingphonecallprescriptions

Page 15: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 15

Baseline DataED/UCEncounters

N=61,984OutpatientEncounters

N=595,479

ED/UCEncounterswithNarcotic/Benzo Prescription

N=18,26629.47%ofED/UC

OutpatientEncounterswithNarcotic/Benzo Prescription

N=22,5243.78%ofOutpatient

PrescribingEncountersw/AlertN=3,265

17.87%ofPrescribingEncounters

5.27%ofTotal

PrescribingEncountersw/AlertN=5.537

24.58%ofPrescribingEncounters

0.93%ofTotal

InpatientDischargesN=12,386

IPDischargeswithNarcotic/Benzo Prescription

N=4,65637.59%ofIPDischarges

CSPrescribingDischargesw/AlertN=1,057

22.70%ofPrescribingDischarges

8.53%ofTotal

Page 16: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 16

“Silent” Surveillance Phase 2: Collecting Baseline Data• 81,841 prescriptions • 2,640

prescriptions/day• 1.33 prescriptions

per prescribing encounter

Characteristic N % of Prescribing Encounters

Age<1818-64>65

1,55245,57114,624

2.5%73.8%23.7%

Facility TypeED/Urgent CareInpatient DischargeOutpatientOther

18,2674,65638,310

514

29.6%7.5%62.0%0.83%

Class of DrugOpiateBenzodiazepineBoth

45,16514,2682,314

73.2%23.1%3.8%

Page 17: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 17

Baseline DataCharacteristic N % of Prescribing

EncountersNumber of Criteria Met012345

48,16410,5172,654369430

78.0%17.0%4.3%

0.60%0.07%0.00%

Criteria MetPrescription with 50% remaining2+ visits with onsite administration3+ prescriptions Positive BAC or tox screenPrevious presentation for overdose

8,3581,2082,8734,165500

13.5%2.0%4.7%6.8%

0.81%

Page 18: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 18

Pilot Phase• One month live in select pilot sites

– CMC Orthopaedics – 2 clinics– CMC-Main/Trauma Center ED– Two regional EDs– Internal Medicine clinic– Family Medicine– Suburban Urgent Care

• Conducted debriefing interviews with prescribers in these sites to gain feedback

Page 19: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 19

Live Intervention• Alert appears to prescribers• Live in all Cerner-driven

CHS facilities (outpatient) July 21, 2015

• Live in ALL Cerner-driven CHS facilities (including inpatient discharge) October 27, 2015

Page 20: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 20

Live Data: Opioids in

Outpatient Setting

Page 21: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 21

Discussion

• Development and tuning in virtual environment vs. live “silent”

Boussadi A, Caruba T, Zapletal E, Sabatier B, Durieux P, Degoulet P. A clinical data warehouse-based process for refining medication orders alerts. J Am Med Inform Assoc. 2012;19(5):782-5.

Oppenheim M, Mintz R, Boyer A, Frayer W. Design of a clinical alert system to facilitate development, testing, maintenance, and user-specific notification. Proc AMIA Symp. 2000:630-4.

Russ AL, Chen S, Melton BL, Saleem JJ, Weiner M, Spina JR et al. Design and evaluation of an electronic override mechanism for medication alerts to facilitate communication between prescribers and pharmacists.

Ann Pharmacother. 2015;49(7):761-9.

Page 22: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 22

Discussion

• Change behavior?

Smith DH, Perrin N, Feldstein A, Yang X, Kuang D, Simon SR et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: An interrupted time series evaluation. Arch Intern Med.

2006;166:1098-104.

Loo TS, Davis RB, Lipsitz LA, Irish J, Bates CK, Agarwal K et al. Electronic medical record reminders and panel management to improve primary care of elderly patients. Arch Intern Med. 2011;171(17):1552-8.

Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. New England Journal of Medicine. 2005;352(10):969-77.

Page 23: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 23

Discussion

• Depends on Alert Fatigue

Feldstein AC, Smith DH, Robertson NR, Kovach CA, Soumerai SB, Simon SR et al. Decision Support System Design and Implementation for Outpatient Prescribing: The Safety in Prescribing Study. In: Henriksen K, Battles JB, Marks ES, editors. Advances in Patient Safety: From Research to Implementation. Rockville, MD: Agency for

Healthcare Research and Quality; 2005. p. 35-50.

Shah NR, Seger AC, Seger DL, Fiskio JM, Kuperman GJ, Blumenfeld B et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13(1):5-11.

van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138-47.

Ulrich B. Alarm fatigue: A growing problem. Nephrology Nursing Journal. 2013;40(4):293

Page 24: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

8/10/16 24

Next Steps• Evaluate Results• Inpatient order intervention• Uniform pain agreement• MME calculator• Dissemination to other sites/EMRs• Collaboration with NCCSRS

Page 25: Prescription Reporting with Immediate Medication ...llrs.org/LLRS 2016 PDFS/Prescription Reporting with...8/10/16 10 Intervention Phases • April-May 2015: 30-day baseline data gathered

Questions/Discussion